ArticleNature2021
Mapping routine measles vaccination in low- and middle-income countries.
Article in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
89 citing papers in PubMed, 2 syntheses or guidelines pooled it, 122 citations in OpenAlex.
- Vaccine equity in low and middle income countries: a systematic review and meta-analysis.International journal for equity in health · 2022Pooled it
- Short message service (SMS) reminders for childhood immunisation in low-income and middle-income countries: a systematic review and meta-analysis.BMJ global health · 2021Pooled it
- Analysis of measles outbreaks reported to Integrated Disease Surveillance Programme (IDSP), India, 2019-2023.BMC infectious diseases · 2026Article
- Assessing Geographic Inequalities in Childhood Immunisation Coverage: A Critical Scoping Review of Spatial Analysis Methods.Vaccines · 2026Article
- The influence of women's empowerment on childhood vaccination coverage in Nigeria: a spatio-temporal analysis.Scientific reports · 2026Article
- Article
- Effective communication and public engagement strategies to counter misinformation about infectious diseases.Immunology and cell biology · 2026Review
- An age-structured spatially varying coefficient model for high-resolution mapping of vaccination coverage.PLoS computational biology · 2026Article
- Estimating the basic reproduction number of measles in low-and middle-income settings using 172 seroprevalence studies: A modelling approach.PLOS global public health · 2026Article
- Article
- Vaccines for microbial eye diseases in the era of data science: opportunities and challenges.Frontiers in immunology · 2026Review
- Determinants of post-campaign measles vaccination coverage in Madagascar: A geographically stratified analysis.PLOS global public health · 2026Article
- Maternal and child healthcare-seeking among victims of violence in armed conflict: a quasi-experimental study in Northeast Nigeria.BMJ global health · 2025Observational
- Validation of VaxEstim, a Bayesian model for rapid estimation of measles-mumps-rubella vaccination coverage at outbreak onset: a cross-sectional study.Lancet regional health. Americas · 2025Article
- Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.Lancet (London, England) · 2025Article
- Prediction of subnational-level vaccination coverage estimates using routine surveillance data and survey data.Vaccine · 2025Article
- Achieving and sustaining measles elimination in Hong Kong, from 1967 to 2024: lessons to be learnt.BMJ global health · 2025Review
- Multiple deprivations as drivers of suboptimal basic child vaccination in Latin America and the Caribbean: cross-sectional analysis of household survey data for 18,136 children across 211 regions in 15 countries.International journal for equity in health · 2025Article
- Microarray patch vaccines for typhoid conjugate vaccines: A global cost-effectiveness analysis.Vaccine · 2025Article
- Epidemiological trends and clinical characteristics of measles in Iraq (2023-2024): a retrospective cross-sectional study.BMC infectious diseases · 2025Article
29 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
1 author at 20 institutions in 64 countries.
Funding
Abstract
The safe, highly effective measles vaccine has been recommended globally since 1974, yet in 2017 there were more than 17 million cases of measles and 83,400 deaths in children under 5 years old, and more than 99% of both occurred in low- and middle-income countries (LMICs)
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.